• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索猫甲状腺肿瘤中的丝裂原活化蛋白激酶(MAPK)和雷帕霉素靶蛋白(mTOR)信号通路。

Exploring MAPK and mTOR Pathways in Feline Thyroid Tumors.

作者信息

Monteiro Alexandra, Gaspar Tiago Bordeira, Borges Inês, Canberk Sule, Pinto Mafalda, Pires Isabel, Soares Paula, Tavares Catarina

机构信息

Cancer Signalling & Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.

Cancer Signalling & Metabolism, IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.

出版信息

Vet Sci. 2025 Jun 24;12(7):617. doi: 10.3390/vetsci12070617.

DOI:10.3390/vetsci12070617
PMID:40711277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12298209/
Abstract

Thyroid tumors are common in humans and cats, occurring most commonly as benign lesions, whereas thyroid carcinoma is barely detected in both species. Determining the mutational status of MAPK-related genes (, , , and ) and the activation status of MAPK and mTOR pathways is crucial for establishing the diagnosis, treatment, and prognosis of human patients. So far, the role of such players in feline thyroid tumorigenesis remains underexplored. This study aims to elucidate the presence and implications of potential shared molecular mechanisms between human and feline thyroid tumors. Fifteen formalin-fixed paraffin-embedded feline thyroid epithelial tumors (four tumors with atypia and 11 with no atypia) were collected to perform mutational and immunohistochemical analyses. Sanger sequencing targeting human homologous hotspots revealed no mutations in (human codon 600) or (human codon 61) regions. A missense mutation (p.Gln232His) was identified in two tumors with no atypia of follicular pattern (2/15, 13%). Regardless of the mutational status, pERK (Thr202/Ty204) was immuno-expressed in 10/11 (91%), pS6 (Ser235/236) in 100%, and pAKT (Ser473) in 8/11 (73%) of the tumors with no atypia. The expression patterns of pERK, pS6, and pAKT and their associations with clinical-pathological features seem to mirror the progression dynamics observed in human thyroid tumorigenesis. pAKT expression was associated with the presence of multiple tumor foci within the same thyroid lobe, suggesting its potential as a marker of aggressiveness in feline thyroid tumors. This study introduces cats as potential animal models for human thyroid tumorigenesis, with further research required to confirm such potential.

摘要

甲状腺肿瘤在人类和猫中都很常见,最常见的是良性病变,而甲状腺癌在这两个物种中都很少被检测到。确定MAPK相关基因( 、 、 和 )的突变状态以及MAPK和mTOR通路的激活状态对于确定人类患者的诊断、治疗和预后至关重要。到目前为止,这些因素在猫甲状腺肿瘤发生中的作用仍未得到充分研究。本研究旨在阐明人类和猫甲状腺肿瘤之间潜在共享分子机制的存在及其意义。收集了15例福尔马林固定石蜡包埋的猫甲状腺上皮肿瘤(4例有异型性肿瘤和11例无异型性肿瘤)进行突变和免疫组化分析。针对人类同源热点的桑格测序显示 (人类密码子600)或 (人类密码子61)区域没有突变。在2例无滤泡型异型性的肿瘤中鉴定出一个错义突变(p.Gln232His)(2/15,13%)。无论突变状态如何,无异型性肿瘤中10/11(91%)的肿瘤免疫表达pERK(Thr202/Ty204),100%的肿瘤免疫表达pS6(Ser235/236),8/11(73%)的肿瘤免疫表达pAKT(Ser473)。pERK、pS6和pAKT的表达模式及其与临床病理特征的关联似乎反映了人类甲状腺肿瘤发生中观察到的进展动态。pAKT表达与同一甲状腺叶内多个肿瘤灶的存在相关,表明其可能作为猫甲状腺肿瘤侵袭性的标志物。本研究将猫引入作为人类甲状腺肿瘤发生的潜在动物模型,需要进一步研究来证实这种潜力。

相似文献

1
Exploring MAPK and mTOR Pathways in Feline Thyroid Tumors.探索猫甲状腺肿瘤中的丝裂原活化蛋白激酶(MAPK)和雷帕霉素靶蛋白(mTOR)信号通路。
Vet Sci. 2025 Jun 24;12(7):617. doi: 10.3390/vetsci12070617.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
4
Osteoarthritis in cats: what we know, and mostly, what we don't know. . . yet.猫的骨关节炎:我们所知道的,以及大多数情况下,我们还不知道的…… 目前。
J Feline Med Surg. 2025 Jul;27(7):1098612X251347999. doi: 10.1177/1098612X251347999. Epub 2025 Jul 20.
5
High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome.高级别滤泡细胞源性非间变性甲状腺癌:侵袭范围和突变谱与肿瘤学结局的相关性
Thyroid. 2025 Feb;35(2):153-165. doi: 10.1089/thy.2024.0499. Epub 2025 Jan 6.
6
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.表皮生长因子受体基因扩增和 PTEN 蛋白表达是 KRAS 野生型转移性结直肠癌患者接受西妥昔单抗治疗的有利预后因素。
J Cancer Res Clin Oncol. 2014 May;140(5):737-48. doi: 10.1007/s00432-014-1626-2. Epub 2014 Mar 5.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
10
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.

本文引用的文献

1
Comparative Cyto-Histological Genetic Profile in a Series of Differentiated Thyroid Carcinomas.一系列分化型甲状腺癌的细胞组织学基因对比图谱
Diagnostics (Basel). 2024 Jan 27;14(3):278. doi: 10.3390/diagnostics14030278.
2
Pathology and new insights in thyroid neoplasms in the 2022 WHO classification.2022 年 WHO 分类中的甲状腺肿瘤病理学与新见解。
Curr Opin Oncol. 2024 Jan 1;36(1):13-21. doi: 10.1097/CCO.0000000000001012. Epub 2023 Nov 17.
3
Clinical Implications of mTOR Expression in Papillary Thyroid Cancer-A Systematic Review.
mTOR表达在甲状腺乳头状癌中的临床意义——一项系统综述
Cancers (Basel). 2023 Mar 8;15(6):1665. doi: 10.3390/cancers15061665.
4
Ensembl 2023.Ensembl 2023.
Nucleic Acids Res. 2023 Jan 6;51(D1):D933-D941. doi: 10.1093/nar/gkac958.
5
Vet-OncoNet: Malignancy Analysis of Neoplasms in Dogs and Cats.兽医肿瘤网络:犬猫肿瘤的恶性分析
Vet Sci. 2022 Sep 28;9(10):535. doi: 10.3390/vetsci9100535.
6
Vet-OncoNet: Developing a Network of Veterinary Oncology and Reporting a Pioneering Portuguese Experience.兽医肿瘤学网络:构建兽医肿瘤学网络并报告葡萄牙的开创性经验。
Vet Sci. 2022 Feb 7;9(2):72. doi: 10.3390/vetsci9020072.
7
Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma.转化肿瘤学中的伴侣动物模型;猫口腔鳞状细胞癌和犬口腔黑色素瘤。
Biology (Basel). 2021 Dec 31;11(1):54. doi: 10.3390/biology11010054.
8
Ensembl 2022.Ensembl 2022.
Nucleic Acids Res. 2022 Jan 7;50(D1):D988-D995. doi: 10.1093/nar/gkab1049.
9
Persistent activation of the mammalian target of rapamycin signalling pathway in cutaneous squamous cell carcinomas in cats.
Vet Dermatol. 2021 Dec;32(6):675-e180. doi: 10.1111/vde.13001. Epub 2021 Jul 8.
10
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.预测甲状腺乳头状癌患者预后的遗传决定因素
Cancers (Basel). 2021 Apr 23;13(9):2048. doi: 10.3390/cancers13092048.